Building Exterior Repair Project � FDA Pacific Southwest Laboratory
FDA · FDA OFFICE OF ACQ GRANT SVCS
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75F40126R00047 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Amendment 0001 is issued to exnted the due date and time while the Government finalizes its resposne to questions. ******************************************* The Mandatory Site Visit Attendee List is posted. Please refer to "75F40126R00047 Site Visit Attendee List 260711". ******************************************** The U.S. Food and Drug Administration (FDA), Office of Facilities Engineering and Mission Support Services (OFEMS), has a requirement for exterior and interior repair and preventative maintenance of the Pacific Southwest Laboratory located at 19701 Fairchild Road, Irvine, Califor… (show all)
nia 92612. The project consists primarily of: � Structural steel surface preparation and application of corrosion-resistant coating systems on exterior stairs, sunshades, roof access stairs, entrance canopies, and chemical storage shed structural components. � Interior and exterior non-structural concrete crack repairs, including associated surface restoration and replacement of damaged resilient flooring where required. � Associated mobilization, quality control testing, safety controls, closeout documentation, and warranty requirements. The facility will remain occupied and operational during construction. Contractors shall coordinate all work with FDA facility personnel and comply with applicable security, safety, and access requirements. The requirement is being solicited as a competitive 100 percent Small Business Set-Aside. TYPE OF CONTRACT: The Government intends to award a Firm-Fixed-Price construction contract. PERIOD OF PERFORMANCE: The Contractor shall achieve substantial completion within 180 calendar days after issuance of the Notice to Proceed (NTP). A one-year workmanship warranty shall be required following final acceptance. WAGE DETERMINATION: Construction Wage Determination CA20260024, Modification 03, dated May 18, 2026, applies to this requirement. BONDS: Performance and Payment Bonds will be required from the successful offeror within fifteen (15) calendar days after contract award. SITE VISIT: A mandatory site visit will be conducted: Date: July 1, 2026 Time: 8:30 AM Pacific Time Location: FDA Pacific Southwest Laboratory Irvine, CA 92612 Registration for the site visit is required no later than June 26, 2026. Attendance is mandatory. Proposals from firms that do not attend the site visit will be considered non-responsive. Interested offerors are advised to thoroughly review the complete solicitation package, including the SF 1442, Performance Work Statement (PWS), drawings, specifications, wage determination, pricing schedule, security requirements, and all attachments and amendments. The Government will not be responsible for an offeror's failure to examine all solicitation documents and site conditions affecting contract performance. Offerors are responsible for ensuring their proposals fully comply with all solicitation requirements, instructions, terms, conditions, specifications, and attachments.
Who won similar work
24 award notices on SAM.gov in the last 24 months. Matched by: Same agency (FDA), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (24): middle half $402K to $19.1M, median $2.6M; range $82K to $120.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Please_See_Spreadsheet Silver Spring MD 20993 USA | 3 | $153.2M | Oct 8, 2026 |
| DCT, INCORPORATED | 1 | $52.8M | Sep 15, 2026 |
| TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC | 1 | $50.0M | Sep 16, 2025 |
| NATI-NVE Support Services, LLC | 1 | $49.0M | May 21, 2026 |
| HARVARD PILGRIM HEALTH CARE INC | 1 | $31.7M | Mar 30, 2026 |
| TOXICOLOGIC PATHOLOGY ASSOCIATES INC | 1 | $26.1M | Sep 15, 2025 |
| IHRC, INCORPORATED | 1 | $14.5M | Sep 16, 2026 |
| VITALANT Scottsdale AZ 85258 USA | 1 | $10.0M | Sep 8, 2025 |
| WE PHARMA, INC. | 1 | $4.0M | Sep 11, 2026 |
| THE BIONETICS CORP | 1 | $2.8M | Jul 21, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Oct 8, 2026Please_See_Spreadsheet Silver Spring MD 20993 USA$120.8MFY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- Sep 24, 2026TRADESPACE INC$82KPlatform Subscription to Support Transfer Program Commercial Assessment Leads
- Sep 24, 2026TURBOFIL PACKAGING MACHINES, LLC$454KAutomated Vial Capper Machine and Labeler system
- Sep 22, 2026ABIDE INTERNATIONAL, INC.$1.8MBuilding Exterior Repair Project � FDA Pacific Southwest Laboratory
- Sep 17, 2026LUSARDI CONSTRUCTION CO. San Marcos CA 92078 USA$779KIRV Exhaust and Vacuum Pump Replacement
- Sep 16, 2026IHRC, INCORPORATED$14.5MFDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ
- Sep 15, 2026DCT, INCORPORATED$52.8MNational Center for Toxicological Research (NCTR) on-site facility Operations and Maintenance (O&M) support services
- Sep 11, 2026WE PHARMA, INC.$4.0MPharmaceutical Products for CDER Research Studies - IDIQ
- Aug 31, 2026GOVERNMENT SCIENTIFIC SOURCE INC$399KDigital Slide Scanner System
- Aug 21, 2026Z-SPEC, INC.$123KPost-Award Public Notice
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
- 0 of their lobbyists list a past Food & Drug Administration (FDA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 129 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.